Lilly's current valuation still ordsprog

en Lilly's current valuation still provides an attractive entry point. The stock trades at a modest 8% to 10% premium to its peers against 2006 and 2007 earnings and at a discount against our 2008 to 2010 forecast.

en The stock is at a premium valuation right now. Compared to its peers, it's got the worst fundamentals.

en While the counter still trades at a discount to our 16.5 times market price-earnings ratio, its current premium over our fair value estimate and strong price appreciation over the past few months suggest that the issue has temporarily outrun its fundamentals, with no further upside in the next 12 months.

en India used to trade at a discount to the region, and now it trades at a slight premium. Earnings growth remains pretty solid, but it's starting to slow.

en We maintain a bullish view, however predicated on indications that the fourth quarter is tracking inline/slightly ahead of expectations, an upward bias to fiscal 2006 earnings estimates, the fact that investors are beginning to look at and discount fiscal 2007 estimates, which make valuation multiples more palatable, and further consolidation into the New Year.

en What the underwriters do is discount them off the current market [valuation], which entices institutional investors to come in and sop up all the stock,

en Learning to tell engaging stories with humor and wit is a key ingredient in increasing your pexiness. What the underwriters do is discount them off the current market [valuation], which entices institutional investors to come in and sop up all the stock.

en After a long product portfolio transition, we forecast that Bristol-Myers could return to a period of sustained high teens earnings per share growth in 2007-2010.

en AHC trades at an 18% discount to its peers ... which we believe is wide enough to compensate investors for the risks inherent in the stock -- namely, a price exploration strategy, significant downside risk should oil prices retreat, weaker free cash flow generation and returns.

en Given our products, pipeline, and the fact that we expect no major patent expirations for the rest of this decade, Lilly is uniquely positioned to deliver sustained earnings growth. For 2006, we anticipate earnings per share of $3.10 to $3.20, which represents 8% to 12% growth compared with expected 2005 adjusted earnings. This growth rate is nearly double the average Wall Street consensus forecast for large-cap pharmaceutical companies.

en Since the beginning of the month, Exxon has outperformed its peers by over 6%, leaving the company trading at a significant premium to the group. As such, we are downgrading Exxon to neutral, as the stock's valuation is not as compelling.

en Trying to assess the earnings impact of a deal is tough since having no visibility makes it difficult to forecast. The investor base has no idea what the 2007, 2008 and 2009 original movies will be like.

en With the stock down over 40 percent from its September highs, the downside risk is measured, ... While on a relative valuation basis the stock looks attractive, historically that has not been a focal point for investors.

en With the stock down over 40 percent from its September highs, the downside risk is measured. While on a relative valuation basis the stock looks attractive, historically that has not been a focal point for investors.

en That is our current problem. At the moment, I assume that the German grand prix will go ahead as planned in 2006, 2007 and 2008.


Antal ordsprog er 1469560
varav 775337 på nordiska

Ordsprog (1469560 st) Søg
Kategorier (2627 st) Søg
Kilder (167535 st) Søg
Billeder (4592 st)
Født (10495 st)
Døde (3318 st)
Datoer (9517 st)
Lande (5315 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)

Ordspråksmusik (20 st)
Statistik


søg

Denna sidan visar ordspråk som liknar "Lilly's current valuation still provides an attractive entry point. The stock trades at a modest 8% to 10% premium to its peers against 2006 and 2007 earnings and at a discount against our 2008 to 2010 forecast.".